.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.the patient was treated at the royal devon & exeter nhs foundation trust.
.
written reports, including local media accounts, professional medical papers and internal emails were also examined.
.
.
.anr is a not for profit organisation that relies on sponsors and donations.
.
.
the uk may have to pay a multimillion-euro fine for air pollution
.
.